You have 9 free searches left this month | for more free features.

sunitinib

Showing 1 - 25 of 179

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refractory Solid Tumors Trial in Seoul (Sunitinib)

Completed
  • Refractory Solid Tumors
  • Sunitinib
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
    University of Miami
Jul 28, 2022

Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer Trial in United States (CGT9486 plus sunitinib, CGT9486, Sunitinib)

Recruiting
  • Advanced Gastrointestinal Stromal Tumors
  • Metastatic Cancer
  • CGT9486 plus sunitinib
  • +2 more
  • Duarte, California
  • +11 more
Aug 10, 2022

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Real-world Clinical Patterns Of Care And Outcomes Among AfME

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Sunitinib
  • Algers, Algeria
  • +5 more
Aug 16, 2022

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Dec 2, 2021

Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

Active, not recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Sunitinib
  • Calgary, Alberta, Canada
  • +3 more
Nov 29, 2021

Brain Metastases Trial in Toronto (Sunitinib)

Active, not recruiting
  • Brain Metastases
  • Sunitinib
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Oct 4, 2021

Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)

Active, not recruiting
  • Kidney Neoplasms
  • Metastatic Renal Cell Cancer
  • Sunitinib
  • Besancon, Franche-ComtĂ©, France
    CHU Besancon
Nov 17, 2021

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma Metastatic
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Jan 5, 2022

CR With Sunitinib Treatment In mRCC Patients

Completed
  • Complete Remission in Renal Cell Carcinoma
  • sunitinib
  • Marseille, Cedex 5, France
  • +13 more
Feb 14, 2022

Non GIST Sarcomas Trial in France (sunitinib)

Completed
  • Non GIST Sarcomas
  • sunitinib
  • Bordeaux, France
  • +5 more
Jan 3, 2022

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Sunitinib
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Renal Cell Carcinoma, Metastatic Trial in Worldwide (Intuvax (INN: ilixadencel), Sunitinib)

Completed
  • Renal Cell Carcinoma, Metastatic
  • Intuvax (INN: ilixadencel)
  • Sunitinib
  • Chicago, Illinois
  • +27 more
Jul 23, 2022

Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)

Terminated
  • Kidney Cancer
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021

Carcinoma, Renal Cell Trial in Durham (Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Sunitinib
  • Durham, North Carolina
    Duke Cancer Institute
Nov 23, 2020

Small Cell Lung Cancer Trial in United States (irinotecan, Carboplatin, sunitinib)

Completed
  • Small Cell Lung Cancer
  • Fort Myers, Florida
  • +9 more
Nov 19, 2021

Metastatic Renal Cell Carcinoma Who Received Sunitinib After 1st

Completed
  • Metastatic Renal Cell Carcinoma (mRCC)
  • sunitinib
  • Calgary, Alberta, Canada
    University of Calgary
Mar 8, 2021

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Completed
  • Renal Cell Cancer Metastatic
  • +2 more
  • Sunitinib
  • Berlin, Germany
    Experimental and Clinical Research Center, Clinical Research Uni
Jan 25, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Renal Cell Carcinoma Who Received First-Line Sunitinib

Completed
  • Metastatic Renal Cell Carcinoma
  • Sunitinib
  • Calgary, Alberta, Canada
    University of Calgary
Feb 19, 2021

Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 Trial in

Recruiting
  • Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
  • Biological : Toripalimab Drug: Axitinib
  • sunitinib
  • Beijing, China
    Beijing Cancer Hospital
Jan 24, 2021

Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Guangzhou, Guangdong, China
  • +20 more
Dec 6, 2021

Metastatic Renal Cell Cancer Trial in France (Pazopanib, Sunitinib)

Completed
  • Metastatic Renal Cell Cancer
  • Bordeaux, France
  • +7 more
Jan 11, 2021